89 related articles for article (PubMed ID: 10949846)
41. [In vitro activity of six beta-lactams against 295 strains of enterobacteriaceae and P. aeruginosa isolated from neutropenic patients].
Maugein J; Perrier F; Cony Makhoul P; Fourche J; Darmaillac V
Pathol Biol (Paris); 1995 Apr; 43(4):253-7. PubMed ID: 7567110
[TBL] [Abstract][Full Text] [Related]
42. [Recent evolution and characterization of extended-spectrum beta-lactamase producing enterobacteria in the CHU of Nice (2005-2007)].
Giraud-Morin C; Fosse T
Pathol Biol (Paris); 2008; 56(7-8):417-23. PubMed ID: 18848404
[TBL] [Abstract][Full Text] [Related]
43. [Evaluation of a new and rapid antibiotic sensitivity method testing for Enterobacteriaceae responsible for urinary infections].
Laudat P; Crouzier C
Pathol Biol (Paris); 1997 May; 45(5):389-93. PubMed ID: 9296090
[TBL] [Abstract][Full Text] [Related]
44. [Frequency and antibiotic susceptibility of bacteria identified in urine].
Sekhsokh Y; Chadli M; El Hamzaoui SA
Med Mal Infect; 2008 Jun; 38(6):324-7. PubMed ID: 18395378
[TBL] [Abstract][Full Text] [Related]
45. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
[TBL] [Abstract][Full Text] [Related]
46. [Resistance to third generation cephalosporins in Sfax hospitals, Tunisia (1999-2005)].
Mkaouar D; Mahjoubi F; Mezghani S; Znazen A; Ktari S; Hammami A
Med Mal Infect; 2008 Jun; 38(6):293-8. PubMed ID: 18191516
[TBL] [Abstract][Full Text] [Related]
47. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
Eser OK; Altun Uludağ H; Ergin A; Boral B; Sener B; Hasçelik G
Mikrobiyol Bul; 2014 Jan; 48(1):59-69. PubMed ID: 24506716
[TBL] [Abstract][Full Text] [Related]
48. Activity of a new cephalosporin antibiotic, Ro 13-9904 against dense populations of selected enterobacteria.
Greenwood D; Eley A
Antimicrob Agents Chemother; 1981 Jan; 19(1):66-71. PubMed ID: 7247361
[TBL] [Abstract][Full Text] [Related]
49. Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria in France. The Comité de l'Antibiogramme de la Société Française de Microbiologie.
Soussy CJ; Cluzel R; Courvalin P
Eur J Clin Microbiol Infect Dis; 1994 Mar; 13(3):238-46. PubMed ID: 8050437
[No Abstract] [Full Text] [Related]
50. Comité de l'Antibiogramme de la Société Française de Microbiologie report 2003.
Members of the SFM Antibiogram Committee
Int J Antimicrob Agents; 2003 Apr; 21(4):364-91. PubMed ID: 12672587
[TBL] [Abstract][Full Text] [Related]
51. Prevalence and Sensitivity of Bacilli and Pseudomonas in the Newborn's Oral Cavity.
Ferreira PVA; Amêndola I; Oliveira LD; Silva CRGE; Leão MVP; Santos SSFD
Braz Dent J; 2017; 28(4):423-427. PubMed ID: 29160392
[TBL] [Abstract][Full Text] [Related]
52. [Comparative analysis of the sensitivity of enterobacteria to bile].
Gritsenko VA; Brudastov IuA; Kudria EV; Vasil'eva LI
Zh Mikrobiol Epidemiol Immunobiol; 2002; (3):65-7. PubMed ID: 12141044
[TBL] [Abstract][Full Text] [Related]
53. [Enterobacteria isolated from cockroaches (Periplaneta americana) captured in a Brazilian hospital].
Prado MA; Pimenta FC; Hayashid M; Souza PR; Pereira MS; Gir E
Rev Panam Salud Publica; 2002 Feb; 11(2):93-8. PubMed ID: 11939120
[TBL] [Abstract][Full Text] [Related]
54. Enterobacteria of the neonate. Normal colonization and antibiotic-induced selection.
Borderon JC; Gold F; Laugier J
Biol Neonate; 1981; 39(1-2):1-7. PubMed ID: 7213865
[TBL] [Abstract][Full Text] [Related]
55. Enterobacteria in feedlot waste and runoff.
Hrubant GR; Daugherty RV; Rhodes RA
Appl Microbiol; 1972 Sep; 24(3):378-83. PubMed ID: 16349932
[TBL] [Abstract][Full Text] [Related]
56. [The sensitivity of enterobacteria to disinfectants].
Krasil'nikov AP; Gudkova EI
Zh Mikrobiol Epidemiol Immunobiol; 1993; (5):22-8. PubMed ID: 8067137
[TBL] [Abstract][Full Text] [Related]
57. Evolution of the barrier effects against an exogenous drug-sensitive Escherichia coli strain after single or repeated oral administration to newborns and infants aged up to three months admitted to an intensive-care unit.
Poisson DM; Borderon JC; Amorim-Sena JC; Laugier J
Biol Neonate; 1986; 49(1):1-7. PubMed ID: 3511977
[TBL] [Abstract][Full Text] [Related]
58. [Various biological properties of enterobacteria, isolated from patients with diarrhea].
Gizatulina SS; Birger MO; Kolyshkina NA
Zh Mikrobiol Epidemiol Immunobiol; 1989 Apr; (4):30-5. PubMed ID: 2735168
[TBL] [Abstract][Full Text] [Related]
59. Automated instrument approaches to clinical microbiology.
Pfaller MA
Diagn Microbiol Infect Dis; 1985 Nov; 3(6 Suppl):15S-23S. PubMed ID: 3905228
[TBL] [Abstract][Full Text] [Related]
60. [Enterobacterial sensitivity to colicins in the presence of enterochelin].
Nazaruk MI; Sibirnyĭ VA; Krilinskaia NE; Kostiukovskaia ON
Zh Mikrobiol Epidemiol Immunobiol; 1980 Sep; (9):70-4. PubMed ID: 6449817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]